Sharemaestro Newsreel

IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year

IceCure Medical Ltd. announced strong financial results for the first half of 2026, reporting a 45% year-over-year revenue growth to $1.8 million, driven by increased sales of its ProSense® systems and disposable probes. The company expanded its U.S. commercial footprint by 70% and ended …

ENVUE Medical (FEED) adds $50M equity facility and boosts $59M Series H rights

ENVUE Medical (FEED) has secured a new committed equity facility of up to $50 million with an institutional investor, allowing the company to sell common shares at its discretion, with 40% of net proceeds earmarked for Series X Preferred Stock redemption. Additionally, the company …

ENvue Medical Secures $50 Million Equity Facility; Expands Series H Investment Rights to $59 Million

ENvue Medical has secured a $50 million committed equity facility with an institutional investor and increased its Series H preferred financing Additional Investment Rights to $59 million. The equity facility allows ENvue to sell common shares at 90% of the lowest VWAP over three …

ENvue Medical Eyes AI, Automation, Acquisitions With Up to $50M

ENvue Medical (NASDAQ: FEED) has secured an equity financing facility of up to $50 million, pending stockholder approval, to boost its financial flexibility. The capital is intended to advance its next-generation medical technology platform, including AI and automation technologies, and to fund strategic acquisitions. …

ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions

ENvue Medical, Inc. announced a securities purchase agreement with an institutional investor for an equity facility of up to $50 million, pending stockholder approval. This financing aims to enhance ENvue's financial flexibility, advance its next-generation technology, and support strategic acquisitions and business development. The …

IceCure's Active U.S. Install Base Grows About 70%; Cash $12M

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

Kenneth Samet Bought 94% More Shares In AdaptHealth

Independent Director Kenneth Samet recently purchased US$150k worth of AdaptHealth (NASDAQ:AHCO) shares at US$6.38 each, increasing his holding by 94%. This insider buying activity, along with other purchases totaling US$511k over the last year, suggests a bullish sentiment despite the company's recent loss. Insiders …

Brainsway earnings matched, revenue topped estimates

Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals

Northside Capital Management LLC Increases Position in GE HealthCare Technologies Inc. $GEHC

Northside Capital Management LLC has increased its stake in GE HealthCare Technologies Inc. by 26.5% during the second quarter, bringing its total holdings to 241,923 shares valued at $15.5 million. This move comes as GE HealthCare reported strong quarterly earnings of $1.13 per share, …

Integer Holdings Corporation (ITGR) Stock Price, News, Quote & History

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50

Treace Medical Concepts (NASDAQ:TMCI) recently released its Q2 earnings, with revenues exceeding expectations at US$45m and statutory losses coming in smaller than anticipated at US$0.24 per share. Following the report, analysts increased their price target for TMCI to US$5.50, reflecting a moderate uplift in …

Wedge Capital Management L L P NC Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

Wedge Capital Management L L P NC significantly increased its stake in GE HealthCare Technologies Inc. by 27.8% in the second quarter, bringing its total holdings to 461,283 shares valued at $29.5 million. This move comes as GE HealthCare reported strong quarterly earnings, exceeding …

Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Hub Group, Inc. (HUBG), Insulet Corporation (PODD), and Photronics, Inc. (PLAB) Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC has announced lead plaintiff deadlines for shareholder class action lawsuits against Hub Group, Inc. (HUBG), Insulet Corporation (PODD), and Photronics, Inc. (PLAB). The lawsuits allege false or misleading statements regarding financial results, revenue recognition, internal controls, manufacturing controls, and product …

2 Growth Stocks with Explosive Upside and 1 Facing Headwinds

2 Growth Stocks with Explosive Upside and 1 Facing Headwinds Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle. …

AI-Enabled Imaging Modalities Market Report: Evaluating AI Software Integration, FDA Approvals, and Competitive Strategies of GE HealthCare, Canon, Siemens, and Philips

Company Logo Accelerating clinical adoption highlighted by GE HealthCare's latest FDA clearance for AI-guided radiation planning, Canon Medical's AI deep-learning CT launch, and strong 2026 order books across Siemens Healthineers and Philips is transforming diagnostic workflows globally. This study delivers an in-depth competitive analysis, …

CODX Q2'26 Earnings: EPS estimate is (3.00) USD

Co-Diagnostics, Inc. (CODX) is scheduled to release its Q2'26 earnings on August 13th, after market close, with an anticipated announcement time of 4:01 PM ET (8:01 PM UTC). Analysts estimate revenue for the quarter to be 132.58 thousand USD and earnings per share (EPS) …

Northside Capital Management LLC Purchases 49,189 Shares of Boston Scientific Corporation $BSX

Northside Capital Management LLC significantly increased its stake in Boston Scientific Corporation by 44.2% in the second quarter, bringing its total holdings to 160,366 shares valued at $6.84 million. The medical equipment provider has a consensus "Moderate Buy" rating from analysts and recently reported …

Abbott Laboratories $ABT Shares Sold by West Branch Capital LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Just Reported Earnings, And Analysts Cut Their Target Price

More Money In The Bank For electroCore Insiders Who Divested US$746k

Despite a recent 46% stock price gain for electroCore, insiders have sold US$746k worth of shares over the past year, primarily by Daniel Goldberger. While some buying occurred, the net insider activity shows more selling than buying, which could signal potential weakness. Insiders currently …

Mobia Medical, Inc. - Common Stock (MOBI) Stock Price, News, Quote & History

Mobia Medical, Inc. (MOBI) reported strong second-quarter revenue of $13.5 million, marking a 102% increase year-over-year due to expanded adoption of its Vivistim therapy. The company has also recently appointed two new independent directors to its board, Myriam Curet, M.D., and Reza Zadno, Ph.D. …

XAIR Q1'26 Earnings: EPS estimate is (10.80) USD

Beyond Air, Inc. (XAIR) is scheduled to announce its Q1'26 earnings on August 13 before the market opens, with results expected at 9:30 AM ET (1:30 PM UTC). Analysts estimate the company will report revenue of $1.93 million and an EPS of ($10.80) for …

Delcath Systems (NASDAQ:DCTH) Stock Rating Upgraded by Zacks Research

Zacks Research has upgraded Delcath Systems (NASDAQ:DCTH) stock from a "hold" to a "strong-buy" rating. This upgrade follows positive earnings results where the company reported $0.07 EPS, significantly beating the estimated loss, and revenue of $29.13 million, exceeding expectations. Other analysts maintain a generally …

How MiRus got $1.5B Boston Scientific investment for heart valve - Atlanta Business Chronicle

Marietta-based MiRus, led by Dr. Jay Yadav, has secured a $1.5 billion investment from Boston Scientific for its heart valve replacement technology. The company is pursuing FDA approval for its innovative heart valve, which utilizes a superalloy, driven by Yadav's personal motivation and past …

Cevian increases Smith & Nephew (NYSE: SNN) holding to 14.21% of votes

Cevian Capital II G.P. Limited has increased its aggregate holding in Smith & Nephew plc to 14.214414% of voting rights, corresponding to 119,179,419 shares. This represents a slight increase from its previously notified holding of 14.010786%, with the additional shares held through Cevian Capital …

Wasatch Advisors LP Sells 94,051 Shares of UFP Technologies, Inc. $UFPT

Wasatch Advisors LP reduced its stake in UFP Technologies (NASDAQ:UFPT) by 12.1% in the second quarter, selling 94,051 shares. Despite the sale, the firm still holds 683,262 shares valued at approximately $181.2 million, representing an 8.83% ownership. Institutional investors own a significant portion of …

Edwards Lifesciences CVP sells $56,966 in company stock By Investing.com

Daniel J. Lippis, CVP at Edwards Lifesciences, sold $56,966 worth of company stock after exercising employee options. This transaction, part of a Rule 10b5-1 trading plan, occurred as the company's stock neared its 52-week high, having delivered a 22.5% return in six months. The …

Form 8K Avita Medical Ltd For: 11 August By Investing.com

This article announces the filing of a Form 8K by Avita Medical Ltd, dated August 11. It's a brief report from Investing.com, typical of regulatory filing announcements. The article provides financial data for various indices, commodities, bonds, and shares, as well as a list …

AVITA Medical Inc (ASX:AVH) Shares Reach 52-Week High at AUD 2.30

AVITA Medical Inc (ASX:AVH) shares reached a new 52-week high of AUD 2.30 on August 12, 2026, closing at AUD 2.28 after a 7.04% increase. The company's market capitalization was approximately AUD 381.9 million, with the stock trading near the top of its annual …

Fulton Bank N.A. Has $2.32 Million Stock Position in Medtronic PLC $MDT

Fulton Bank N.A. significantly increased its stake in Medtronic PLC by 65.1% in the second quarter, bringing its total holdings to 29,675 shares valued at $2.32 million. This move comes as Medtronic exceeded earnings and revenue expectations and raised its quarterly dividend. Analysts maintain …

NovoCure (NVCR) Is Up 8.5% After Advancing Tumor Treating Fields Pipeline And Trials Progress - Has The Bull Case Changed?

NovoCure (NVCR) saw an 8.5% stock increase following advancements in its tumor treating fields pipeline, including devices like Optune Gio and Optune Lua, and progress in clinical trials for solid tumor cancers. While these developments reinforce the core thesis around TTFields technology, the investment …

Should Penumbra’s RED 68 Catheter Recall and Margin Strain Require Action From Penumbra (PEN) Investors?

Penumbra, Inc. recently initiated a Class II recall of its RED 68 Reperfusion Catheter due to manufacturing issues, coinciding with a quarter reporting higher sales but lower net income and reduced earnings per share. This recall adds to existing margin pressures and raises concerns …

Penumbra, Inc. (PEN) stock price, news, quote and history

This article provides a comprehensive overview of Penumbra, Inc. (PEN), a medical device company, including its current stock price, historical data, financial performance, and analyst insights. It details the company's product offerings in neurosurgical and peripheral thrombectomy devices and outlines key financial metrics and …

Delcath Systems (NASDAQ:DCTH) Hits New 12-Month High - Here's What Happened

Delcath Systems (NASDAQ:DCTH) recently reached a new 52-week high, trading as high as $17.42. The stock experienced positive sentiment from analysts, with HC Wainwright maintaining a "Buy" rating and increasing its price target, and Zacks identifying it as a potential momentum stock. Despite a …